Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation
- PMID: 39287388
- PMCID: PMC11495019
- DOI: 10.1128/jvi.01072-24
Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation
Abstract
The Envelope (E) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an integral structural protein in the virus particles. However, its role in the assembly of virions and the underlying molecular mechanisms are yet to be elucidated, including whether the function of E protein is regulated by post-translational modifications. In the present study, we report that SARS-CoV-2 E protein is palmitoylated at C40, C43, and C44 by palmitoyltransferases zDHHC3, 6, 12, 15, and 20. Mutating these three cysteines to serines (C40/43/44S) reduced the stability of E protein, decreased the interaction of E with structural proteins Spike, Membrane, and Nucleocapsid, and thereby inhibited the production of virus-like particles (VLPs) and VLP-mediated luciferase transcriptional delivery. Specifically, the C40/43/44S mutation of E protein reduced the density of VLPs. Collectively, these results demonstrate that palmitoylation of E protein is vital for its function in the assembly of SARS-CoV-2 particles.IMPORTANCEIn this study, we systematically examined the biochemistry of palmitoylation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) E protein and demonstrated that palmitoylation of SARS-CoV-2 E protein is required for virus-like particle (VLP) production and maintaining normal particle density. These results suggest that palmitoylated E protein is central for proper morphogenesis of SARS-CoV-2 VLPs in densities required for viral infectivity. This study presents a significant advancement in the understanding of how palmitoylation of viral proteins is vital for assembling SARS-CoV-2 particles and supports that palmitoyl acyltransferases can be potential therapeutic targets for the development of SARS-CoV-2 inhibitors.
Keywords: Envelope protein; SARS-CoV-2; palmitoylation; virus-like particles.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.J Biol Chem. 2021 Jan-Jun;296:100111. doi: 10.1074/jbc.RA120.016175. Epub 2020 Dec 3. J Biol Chem. 2021. PMID: 33229438 Free PMC article.
-
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.J Biol Chem. 2021 Jan-Jun;296:100103. doi: 10.1074/jbc.RA120.016148. Epub 2020 Nov 27. J Biol Chem. 2021. PMID: 33214224 Free PMC article.
-
Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.Cells. 2021 Apr 9;10(4):853. doi: 10.3390/cells10040853. Cells. 2021. PMID: 33918600 Free PMC article.
-
Structural basis of severe acute respiratory syndrome coronavirus 2 infection.Curr Opin HIV AIDS. 2021 Jan;16(1):74-81. doi: 10.1097/COH.0000000000000658. Curr Opin HIV AIDS. 2021. PMID: 33186231 Review.
-
Protein post-translational modification in SARS-CoV-2 and host interaction.Front Immunol. 2023 Jan 13;13:1068449. doi: 10.3389/fimmu.2022.1068449. eCollection 2022. Front Immunol. 2023. PMID: 36713387 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
- 2018YFE0107600/Key international Cooperation Project of the National Key Research and Development Program of China
- CIFMS 2022-I2M-CoV19-002/CAMS Innovation Fund for Medical Sciences
- 82271802, 82241073/National Natural Science Foundation of China (NSFC)
- 63201023/Fundamental Research Funds for the Central Universities, Nankai University
- 63201102/Fundamental Research Funds for the Central Universities, Nankai University
LinkOut - more resources
Full Text Sources
Miscellaneous